Effect of supplementary calcium phosphate on plasma gastrointestinal hormones in a double-blind, placebo-controlled, cross-over human study

British Journal of Nutrition

Volumn 111, Issue 2, 2014, Pages 287-293

  Trautvetter, Ulrike ^a   Jahreis, Gerhard ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Calcium phosphate; Gastrointestinal hormones; Glucagon like peptides; Glucose dependent insulinotropic polypeptide; Human studies

Indexed keywords

CALCIUM PHOSPHATE; GASTRIC INHIBITORY POLYPEPTIDE; GASTROINTESTINAL HORMONE; GLUCAGON LIKE PEPTIDE 1; GLUCAGON LIKE PEPTIDE 2; GLUCOSE; INSULIN; PENTACALCIUM HYDROXY TRIPHOSPHATE; PLACEBO; UNCLASSIFIED DRUG; PENTACALCIUM HYDROXYTRIPHOSPHATE;

ADULT; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; BONE METABOLISM; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FOOD ANALYSIS; HORMONAL REGULATION; HORMONE RELEASE; HORMONE RESPONSE; HUMAN; MALE; NUTRITIONAL ASSESSMENT; OUTCOME ASSESSMENT; POSTPRANDIAL STATE; RANDOMIZED CONTROLLED TRIAL; YOUNG ADULT; CALCIUM INTAKE; CONTROLLED CLINICAL TRIAL; GLUCOSE BLOOD LEVEL; HORMONE BLOOD LEVEL; INSULIN BLOOD LEVEL; TEST MEAL; WHEAT; ADOLESCENT; AREA UNDER THE CURVE; BLOOD; FEMALE; METABOLISM;

ADOLESCENT; ADULT; AREA UNDER CURVE; BLOOD GLUCOSE; CALCIUM PHOSPHATES; CROSS-OVER STUDIES; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; GASTROINTESTINAL HORMONES; GLUCOSE; HUMANS; INSULIN; MALE;

EID: 84896666492     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114513002341     Document Type: Article

References (43)

1. Phillips LK & Prins JB (2011) Update on incretin hormones. Ann N Y Acad Sci 1243, E55-E74.
2. Estall JL & Drucker DJ (2006) Glucagon-like peptide-2. Annu Rev Nutr 26, 391-411.
3. Buchan AMJ, Polak JM, Capella C, et al. (1978) Electron- immunocytochemical evidence for the K cell localization of gastric inhibitory polypeptide (GIP) in man. Histochemistry 56, 37-44.
4. Moody AJ, Thim L & Valverde I (1984) The isolation and sequencing of human gastric inhibitory peptide (GIP). FEBS Lett 172, 142-148.
5. Eissele R, Goke R, Willemer S, et al. (1992) Glucagon-like peptide-1 cells in the gastrointestinal tract and pancreas of rat, pig and man. Eur J Clin Invest 22, 283-291.
6. Seino Y, Fukushima M & Yabe D (2010) GIP and GLP-1, the two incretin hormones: similarities and differences. J Diabetes Invest 1, 8-23.
7. Jeppesen PB, Lund P, Gottschalck IB, et al. (2009) Short bowel patients treated for two years with glucagon-like peptide 2 (GLP-2): compliance, safety, and effects on quality of life. Gastroenterol Res Pract 2009, article ID 425759.
8. Yamada Y, Miyawaki K, Tsukiyama K, et al. (2006) Pancreatic and extrapancreatic effects of gastric inhibitory polypeptide. Diabetes 55, S86-S91.
9. Tsukiyama K, Yamada Y, Yamada C, et al. (2006) Gastric inhibitory polypeptide as an endogenous factor promoting new bone formation after food ingestion. Mol Endocrinol 20, 1644-1651.
10. Yamada C, Yamada Y, Tsukiyama K, et al. (2008) The murine glucagon-like peptide-1 receptor is essential for control of bone resorption. Endocrinology 149, 574-579.
11. Henriksen DB, Alexandersen P, Bjarnason NH, et al. (2003) Role of gastrointestinal hormones in postprandial reduction of bone resorption. J Bone Miner Res 18, 2180-2189.
12. Henriksen DB, Alexandersen P, Hartmann B, et al. (2007) Disassociation of bone resorption and formation by GLP-2-a 14-day study in healthy postmenopausal women. Bone 40, 723-729.
13. Heaney RP, Recker RR, Watson P, et al. (2010) Phosphate and carbonate salts of calcium support robust bone building in osteoporosis. Am J Clin Nutr 92, 101-105.
14. Bonjour JP (2011) Calcium and phosphate: a duet of ions playing for bone health. J Am Coll Nutr 30, 438S-448S.
15. Trautvetter U, Kiehntopf M & Jahreis G (2013) Postprandial effects of calcium phosphate supplementation on plasma concentration-double-blind, placebo-controlled cross-over human study. Nutr J 12, 30.
16. Lapre JA, De Vries HT & Van der Meer R (1991) Dietary calcium phosphate inhibits cytotoxicity of fecal water. Am J Physiol Gastrointest Liver Physiol 261, G907-G912.
17. Ditscheid B, Keller S & Jahreis G (2005) Cholesterol metabolism is affected by calcium phosphate supplementation in humans. J Nutr 135, 1678-1682.
18. Van der Meer R, Welberg JWM, Kuipers F, et al. (1990) Effects of supplemental dietary calcium on the intestinal association of calcium, phosphate, and bile-acids. Gastroenterology 99, 1653-1659.
19. Lorenzen JK, Nielsen S, Holst JJ, et al. (2007) Effect of dairy calcium or supplementary calcium intake on postprandial fat metabolism, appetite, and subsequent energy intake. Am J Clin Nutr 85, 678-687.
20. Reid IR, Cornish J & Baldock PA (2006) Nutrition-related peptides and bone homeostasis. J Bone Miner Res 21, 495-500.
21. Wong IP, Baldock PA & Herzog H (2010) Gastrointestinal peptides and bone health. Curr Opin Endocrinol Diabetes Obes 17, 44-50.
22. Toyota T, Nakanome C, Akai H, et al. (1982) Release of gastric inhibitory polypeptide (GIP) during calcium infusion and in hyperparathyroidism. Regul Pept 4, 1-12.
23. Trautvetter U, Ditscheid B, Kiehntopf M, et al. (2012) A combination of calcium phosphate and probiotics beneficially influences intestinal lactobacilli and cholesterol metabolism in humans. Clin Nutr 31, 230-237.
24. Govers MJ, Termont DS, Van Aken GA, et al. (1994) Characterization of the adsorption of conjugated and unconjugated bile acids to insoluble, amorphous calcium phosphate. J Lipid Res 35, 741-748.
25. Ditscheid B, Keller S & Jahreis G (2009) Faecal steroid excretion in humans is affected by calcium supplementation and shows gender-specific differences. Eur J Nutr 48, 22-30.
26. Bovee-Oudenhoven IM, Wissink ML, Wouters JT, et al. (1999) Dietary calcium phosphate stimulates intestinal lacto-bacilli and decreases the severity of a salmonella infection in rats. J Nutr 129, 607-612.
27. Govers MJ, Termont DS, Lapre JA, et al. (1996) Calcium in milk products precipitates intestinal fatty acids and secondary bile acids and thus inhibits colonic cytotoxicity in humans. Cancer Res 56, 3270-3275.
28. Van der Meer R, Termont DS & De Vries HT (1991) Differential effects of calcium ions and calcium phosphate on cytotoxicity of bile acids. Am J Physiol 260, G142-G147.
29. Katsuma S, Hirasawa A & Tsujimoto G (2005) Bile acids promote glucagon-like peptide-1 secretion through TGR5 in a murine enteroendocrine cell line STC-1. Biochem Biophys Res Commun 329, 386-390.
30. Beysen C, Murphy EJ, Deines K, et al. (2012) Effect of bile acid sequestrants on glucose metabolism, hepatic de novo lipogen-esis, and cholesterol and bile acid kinetics in type 2 diabetes: a randomised controlled study. Diabetologia 55, 432-442.
31. Brufau G, Stellaard F, Prado K, et al. (2010) Improved glycemic control with colesevelam treatment in patients with type 2 diabetes is not directly associated with changes in bile acid metabolism. Hepatology 52, 1455-1464.
32. Van der Meer R & De Vries HT (1985) Differential binding of glycine-conjugated and taurine-conjugated bile-acids to insoluble calcium-phosphate. Biochem J 229, 265-268.
33. Tappenden KA, Albin DM, Bartholome AL, et al. (2003) Glucagon-like peptide-2 and short-chain fatty acids: a new twist to an old story. J Nutr 133, 3717-3720.
34. Diamant M, Blaak EE & De Vos WM (2011) Do nutrient-gut-microbiota interactions play a role in human obesity, insulin resistance and type 2 diabetes? Obes Rev 12, 272-281.
35. Cani PD, Lecourt E, Dewulf EM, et al. (2009) Gut microbiota fermentation of prebiotics increases satietogenic and incretin gut peptide production with consequences for appetite sensation and glucose response after a meal. Am J Clin Nutr 90, 1236-1243.
36. Frost GS, Brynes AE, Dhillo WS, et al. (2003) The effects of fiber enrichment of pasta and fat content on gastric emptying, GLP-1, glucose, and insulin responses to a meal. Eur J Clin Nutr 57, 293-298.
37. Greenway F, O'Neil CE, Stewart L, et al. (2007) Fourteen weeks of treatment with Viscofiber increased fasting levels of glucagon-like peptide-1 and peptide-YY. J Med Food 10, 720-724.
38. Thomsen C, Rasmussen O, Lousen T, et al. (1999) Differential effects of saturated and monounsaturated fatty acids on postprandial lipemia and incretin responses in healthy subjects. Am J Clin Nutr 69, 1135-1143.
39. Cope MB & Allison DB (2008) Critical review of the World Health Organization's (WHO) 2007 report on 'evidence of the long-term effects of breastfeeding: systematic reviews and meta-analysis' with respect to obesity. Obes Rev 9, 594-605.
40. Weyermann M, Rothenbacher D & Brenner H (2006) Duration of breastfeeding and risk of overweight in childhood: a prospective birth cohort study from Germany. Int J Obes 30, 1281-1287.
41. Srinivasan M, Laychock SG, Hill DJ, et al. (2003) Neonatal nutrition: metabolic programming of pancreatic islets and obesity. Exp Biol Med (Maywood) 228, 15-23.
42. Ailhaud G, Massiera F, Weill P, et al. (2006) Temporal changes in dietary fats: role of n-6 polyunsaturated fatty acids in excessive adipose tissue development and relationship to obesity. Prog Lipid Res 45, 203-236.
43. Oosting A, van Vlies N, Kegler D, et al. (2013) Effect of dietary lipid structure in early postnatal life on mouse adipose tissue development and function in adulthood. Br J Nutr 111, 215-226.